A Food and Drug Administration expert panel has recommended against expanding the approval of a Johnson & Johnson drug, the company said.
Walmart and Sam's Club will be among the first retailers to offer a generic version of an antiplatelet drug.
A recent clinical trial involving a new drug formulation incorporating aspirin with soy-derived phosphatidylcholine found that the drug combination significantly can reduce irritation to the stomach and upper gastrointestinal tract.